Reaction Details Report a problem with these data
Target
Alpha-1D adrenergic receptor
Ligand
BDBM50213527
Substrate
n/a
Meas. Tech.
ChEMBL_438894 (CHEMBL889237)
Ki
26±n/a nM
Citation
 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS). Bioorg Med Chem Lett 17:3930-4 (2007) [PubMed]  Article 
Target
Name:
Alpha-1D adrenergic receptor
Synonyms:
ADA1D_HUMAN | ADRA1A | ADRA1D | Adrenergic receptor | Adrenergic receptor alpha | Alpha 1D-adrenoceptor | Alpha 1D-adrenoreceptor | Alpha adrenergic receptor (1a and 1d) | Alpha-1D adrenoceptor | Alpha-adrenergic receptor 1a | adrenergic Alpha1D
Type:
Enzyme Catalytic Domain
Mol. Mass.:
60485.82
Organism:
Homo sapiens (Human)
Description:
adrenergic Alpha1D ADRA1D HUMAN::P25100
Residue:
572
Sequence:
MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI
  
Inhibitor
Name:
BDBM50213527
Synonyms:
CHEMBL228390 | N-((1r,4r)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide
Type:
Small organic molecule
Emp. Form.:
C27H33F3N2O5S
Mol. Mass.:
554.622
SMILES:
FC(F)(F)COc1ccccc1C1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,wD:21.26,(18.05,-19.16,;17.29,-20.51,;18.63,-21.27,;15.95,-19.75,;16.52,-21.84,;17.3,-23.18,;16.52,-24.52,;15,-24.52,;14.21,-25.84,;14.98,-27.19,;16.52,-27.19,;17.3,-25.85,;18.85,-25.85,;19.62,-27.2,;21.15,-27.2,;21.92,-25.87,;21.16,-24.55,;19.62,-24.52,;23.49,-25.87,;24.25,-24.55,;25.78,-24.59,;26.54,-25.9,;25.78,-27.22,;24.26,-27.22,;28.12,-25.9,;28.87,-24.6,;27.55,-23.83,;30.23,-25.37,;29.64,-23.25,;28.88,-21.93,;29.65,-20.58,;31.21,-20.58,;31.99,-19.25,;33.53,-19.26,;34.29,-20.6,;33.51,-21.93,;31.96,-21.93,;31.2,-23.25,)|
Structure:
Search PDB for entries with ligand similarity: